Eli Lilly and Company Stock Up 0.0 % Shares of NYSE:LLY opened at $924.05 on Tuesday. The company has a quick ratio of 0.87, a current ratio of 1.11 and a debt-to-equity ratio of 1.74. The company ...

Eli Lilly and Company Stock Down 1.1 % NYSE LLY opened at $902.71 on Friday. Eli Lilly and Company has a 52 week low of $516.57 and a 52 week high of $972.53. The company has a quick ratio of 0.87 ...

Eli Lilly and Company (NYSE: LLY) announced today the U.S. Food and Drug Administration (FDA) approved EBGLYSS™ (lebrikizumab ...

Two new papers by a team of researchers at Boston University, the Indiana University School of Medicine and the Alzheimer’s Disease Neuroimaging Initiative (ADNI), and the German Center for ...

OrbiMed Advisors LLC, a prominent investment firm, executed a significant transaction by acquiring an additional 6,807,336 shares of Terns Pharmaceuticals Inc (NASDAQ:TERN). This purchase was made at ...

The Journal sat down with Colleen Dixon, the new CEO of Spokane-based Selkirk Pharma Inc., to discusswhat the company has been up to in the last couple of years and what Dixon is focused on ...

‘Comparative effects of drug interventions for the acute management of migraine episodes in adults: systematic review and network meta-analysis’ by William K Karlsson et al. was published in The BMJ ...